2m 2m 2m 2m 2m 2m 2m
MediciNova (MNOV)
NASDAQ
$1.32$0.00 (0.00%)
Price as of Jun 03, 2026 4:10 PM EDT- $66.9MMarket Cap
- -7.69%1-Year Change
- BiotechnologyIndustry
MediciNova (MNOV)
$1.32$0.00 (0.00%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 409,657 -59.03% | 1.0M 0.00% | 1.0M -75.23% | 4.0M 0.00% | |
Cost of Revenue | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Gross Profit | 409,657 -59.03% | 1.0M 0.00% | 1.0M -75.23% | 4.0M 0.00% | |
Sales and Marketing Expense | 378,606 N/A | N/A N/A | N/A N/A | N/A N/A | |
Research and Development Expense | -7.2M -0.55% | -7.2M +27.16% | -5.7M -38.12% | -9.1M +7.09% | |
Depreciation and Amortization Expense | 20,099 -4.64% | 21,077 +3.85% | 20,295 +14.62% | 17,707 -32.28% | |
Total Operating Expenses | 13.7M +8.03% | 12.7M +16.28% | 10.9M -25.49% | 14.6M +2.63% | |
Operating Profit | -13.3M +4.79% | -12.7M +28.03% | -9.9M -32.32% | -14.6M +43.20% | |
Interest Income | 1.3M -21.97% | 1.7M -8.93% | 1.8M +126.59% | 809,673 +463.74% | |
Interest Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Interest Income and Expense and Net | 1.3M -21.97% | 1.7M -8.93% | 1.8M +126.59% | 809,673 +463.74% | |
Total Nonoperating Income and Expense | -12,753 -67.70% | -39,485 -92.15% | -502,869 +103.36% | -247,285 +315.62% | |
Income before Taxes | -12.0M +8.58% | -11.0M +28.89% | -8.6M -39.08% | -14.1M +38.83% | |
Income Taxes | 5,994 +8.25% | 5,537 +81.72% | 3,047 +7.97% | 2,822 +9.89% | |
Extraordinary Items | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Net Income | -12.0M +8.58% | -11.0M +28.91% | -8.6M -39.08% | -14.1M +38.83% | |
Net Income from Continuing Operations Applicable to Common | -12.0M +8.58% | -11.0M +28.89% | -8.6M -39.08% | -14.1M +38.83% | |
Basic EPS and Net Income | -0.24 +4.35% | -0.23 +35.29% | -0.17 -41.38% | -0.29 +38.10% | |
Diluted EPS and Net Income | -0.24 +4.35% | -0.23 +35.29% | -0.17 -41.38% | -0.29 +38.10% | |
Basic Weighted Average Shares | 49.1M +0.04% | 49.0M 0.00% | 49.0M +0.002% | 49.0M +0.92% | |
Diluted Weighted Average Shares | 49.1M +0.04% | 49.0M 0.00% | 49.0M +0.002% | 49.0M +0.92% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 30.8M -23.67% | 40.4M -20.86% | 51.0M +175.59% | 18.5M -74.09% | |
Short-Term Investments | N/A N/A | N/A N/A | 40.0M 0.00% | 40.0M N/A | |
Cash and Cash Equivalents and Short-Term Investments | 30.8M -23.67% | 40.4M -55.64% | 91.0M +55.56% | 58.5M -18.12% | |
Total Current Assets | 31.0M -24.55% | 41.1M -19.74% | 51.2M -13.24% | 59.0M -18.08% | |
Accumulated Depreciation | 422,809 +4.98% | 402,734 -9.19% | 443,513 +2.48% | 432,800 +1.79% | |
Property and Plant and Equipment and Net | 8,340 -67.30% | 25,507 -44.31% | 45,800 +1.17% | 45,269 -21.36% | |
Total Long-Term Assets | 18,996 0.00% | 18,996 -74.38% | 74,151 -20.09% | 92,792 -19.66% | |
Total Assets | 45.6M -18.39% | 55.9M -15.68% | 66.3M -10.63% | 74.2M -15.16% | |
Income Taxes Payable | 201,792 0.00% | 201,792 0.00% | 201,792 0.00% | 201,792 0.00% | |
Total Short-Term Debt | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Current Liabilities | 3.8M +28.33% | 3.0M -9.76% | 3.3M +2.88% | 3.2M +12.52% | |
Total Long-Term Debt | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Long-Term Liabilities | 17,129 -91.90% | 211,460 -48.51% | 410,660 -21.57% | 523,619 -24.62% | |
Total Liabilities | 4.0M +19.10% | 3.4M -13.34% | 3.9M -0.54% | 3.9M +4.92% | |
Retained Earnings | -438.7M +2.81% | -426.8M +2.66% | -415.7M +2.11% | -407.1M +3.58% | |
Total Stockholders Equity | 41.6M -20.79% | 52.5M -15.83% | 62.4M -11.20% | 70.2M -16.06% | |
Total Shares Outstanding | 49.2M +0.36% | 49.0M 0.00% | 49.0M 0.00% | 49.0M +0.006% | |
Cash Flow | |||||
Cash from Operating Activities | -9.8M -7.83% | -10.6M +43.22% | -7.4M -42.45% | -12.9M +37.63% | |
Capital Expenditures | 2,899 +223.91% | 895 -95.80% | 21,299 +325.13% | 5,010 -82.56% | |
Cash from Investing Activities | -2,899 +315.93% | -697 -100.00% | 39.9M +199.76% | -40.0M +139,135.03% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | 244,018 N/A | N/A N/A | 7,920 0.00% | 7,920 -99.96% | |
Financials Ratio | |||||
Gross Margin | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Operating Margin | -3,242.47% +155.81% | -1,267.53% +28.03% | -990.03% +173.25% | -362.32% +43.20% | |
Return on Assets | -23.65% +30.70% | -18.09% +48.20% | -12.21% -29.91% | -17.42% +39.91% | |
Return on Equity | -25.50% +32.58% | -19.24% +48.81% | -12.93% -29.29% | -18.28% +39.80% | |
Revenue Growth | -59.03% N/A | 0.00% +100.00% | -75.23% N/A | 0.00% N/A | |
Current Ratio | 8.16 -41.21% | 13.88 -11.06% | 15.61 -15.67% | 18.51 -27.20% | |
Cash Ratio | 8.11 -40.52% | 13.64 -12.31% | 15.55 +167.89% | 5.81 -76.97% | |
Debt-to-Equity Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Debt-to-Assets Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow